Investigation of Genetic Variants Related to Arterial Aneurysms and/or Dissections with Clinical Suspicion for Connective Tissue Disease

Overview

About this study

The purpose of this study is to perform studies to identify mutations in ACTA2, MYH11, and potentially other genes in individuals with with arterial aneurysms and/or dissections with clinical suspicion for connective tissue disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Patients of all ages with arterial aneurysms and/or dissections with clinical suspicion for connective tissue disease and their available family members.

Exclusion Criteria

Not able to provide written informed consent or assent.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Linnea Baudhuin, Ph.D.	Closed for enrollment	Contact information: Linnea Baudhuin Ph.D. (507)284-3374

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Linnea Baudhuin, Ph.D.

Closed for enrollment

Contact information:

Linnea Baudhuin Ph.D.

(507)284-3374

More information

Publications

Publications are currently not available

Clinical Trials